Insiders · BIOL

Michael DiTolla

Director at Biolase, Inc (BIOL)

Michael DiTolla has filed 1 insider report with the SEC since June 2021, as director at Biolase, Inc (BIOL). The latest filing, on June 15, 2021, reports grant or award at Biolase, Inc (BIOL).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Michael DiTolla is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Biolase, Inc logo
BIOL
Biolase, Inc
DirectorJun 15, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Questions about Michael DiTolla

What is Michael DiTolla's role at Biolase, Inc?
Michael DiTolla reports to the SEC as director at Biolase, Inc (BIOL), according to the latest filing on June 15, 2021.
Has Michael DiTolla bought or sold stock recently?
No open-market purchases or sales by Michael DiTolla are on file. The filings report grant or award.
How do I get alerts when Michael DiTolla files?
Follow Michael DiTolla on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Michael DiTolla (SEC CIK 0001794696). Totals count each trade once, skipping amendments whose original is on file, from Jun 15, 2021 on. View on SEC EDGAR